tirzepatide semaglutide conversion Dose-equivalence reference based on pivotal GLP-1/dual-agonist trials: SURMOUNT-1 (tirzepatide/Zepbound, 72 weeks) STEP-1 (subcutaneous semaglutide/Wegovy, 68 weeks) OASIS-4 (oral semaglutide/Wegovy, 64 weeks). For educational comparison only—these are can you switch between tirzepatide

Information should cover comprehensive macronutrient and micronutrient values

While many different things can increase your risk for gout, what you eat has actually been found to be one of the top contributing factors

The recommended maintenance dosage of Wegovy tablets is 25 mg orally once daily

Since most glucose-dependent insulinotropic polypeptide (GIP) receptor: glucagon-like peptide- 1 receptor (GLP- 1) receptor: glucagon receptor triagonists compete in efficacy with bariatric surgery, the success of these agents in preclinical models and clinical trials suggests a bright future for multi-agonists in the treatment of metabolic diseases

1 in 3 Say Anticipated Savings Drove Their GLP-1 Decision Nearly half of respondents 45% say they anticipated saving money on expenses such as food, restaurants, or fitness before starting a GLP-1

Pregnancy and other considerations GLP-1 and GIP medications are not recommended during pregnancy